BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile

Reuters

Oct 14, 2025

BRIEF-BioCryst To Acquire Astria <a href="https://laohu8.com/S/LENZ">Therapeutics</a>, Strengthening Presence In Hae, Transforming Growth Profile

Oct 14 (Reuters) - Astria Therapeutics Inc ATXS.O:

BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE
BIOCRYST PHARMACEUTICALS- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE
ASTRIA THERAPEUTICS INC - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE
ASTRIA THERAPEUTICS INC - BIOCRYST ENTERS $550 MILLION FINANCING FACILITY WITH BLACKSTONE
ASTRIA THERAPEUTICS INC: EXPECTS CASH PORTION OF DEAL CONSIDERATION TO BE FUNDED WITH CASH ON HAND & PART OF BLACKSTONE FACILITY

Source text: ID:nBw4gdxGBa

Further company coverage: ATXS.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2575129463"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575129463\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575129463?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-14 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575129463","market":"us","top_or_hot":-1,"title":"BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioCryst To Acquire Astria <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Strengthening Presence In Hae, Transforming Growth Profile</title></head><body><p><span>Oct 14 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ATXS\">Astria Therapeutics Inc</a> <span>ATXS.O</span>:</p><ul><li><p>BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE</p></li><li><p>BIOCRYST PHARMACEUTICALS- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE</p></li><li><p>ASTRIA THERAPEUTICS INC - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE</p></li><li><p>ASTRIA THERAPEUTICS INC - BIOCRYST ENTERS $550 MILLION FINANCING FACILITY WITH BLACKSTONE</p></li><li><p>ASTRIA THERAPEUTICS INC: EXPECTS CASH PORTION OF DEAL CONSIDERATION TO BE FUNDED WITH CASH ON HAND &amp; PART OF BLACKSTONE FACILITY</p></li></ul><p>Source text: <span>ID:nBw4gdxGBa</span></p><p>Further company coverage: <span>ATXS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-14 19:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioCryst To Acquire Astria <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, Strengthening Presence In Hae, Transforming Growth Profile</title></head><body><p><span>Oct 14 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ATXS\">Astria Therapeutics Inc</a> <span>ATXS.O</span>:</p><ul><li><p>BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE</p></li><li><p>BIOCRYST PHARMACEUTICALS- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE</p></li><li><p>ASTRIA THERAPEUTICS INC - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE</p></li><li><p>ASTRIA THERAPEUTICS INC - BIOCRYST ENTERS $550 MILLION FINANCING FACILITY WITH BLACKSTONE</p></li><li><p>ASTRIA THERAPEUTICS INC: EXPECTS CASH PORTION OF DEAL CONSIDERATION TO BE FUNDED WITH CASH ON HAND &amp; PART OF BLACKSTONE FACILITY</p></li></ul><p>Source text: <span>ID:nBw4gdxGBa</span></p><p>Further company coverage: <span>ATXS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BCRX","symbol_name":"BioCryst制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUA30LKMH:1","article_id":"2575129463","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575129463","pubTimestamp":1760440589,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth ProfileOct 14 (Reuters) - Astria Therapeutics Inc ATXS.O:BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BCRX":"BioCryst制药","BK4139":"生物科技","ATXS":"Astria Therapeutics Inc","BK4547":"WSB热门概念"},"translate_title":"简介-BioCryst将收购Astria Therapeutics，加强在Hae领域的业务，改变增长状况","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATXS":0.9,"BCRX":0.9},"content_text":"BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth ProfileOct 14 (Reuters) - Astria Therapeutics Inc ATXS.O:BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILEBIOCRYST PHARMACEUTICALS- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUEASTRIA THERAPEUTICS INC - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHAREASTRIA THERAPEUTICS INC - BIOCRYST ENTERS $550 MILLION FINANCING FACILITY WITH BLACKSTONEASTRIA THERAPEUTICS INC: EXPECTS CASH PORTION OF DEAL CONSIDERATION TO BE FUNDED WITH CASH ON HAND & PART OF BLACKSTONE FACILITYSource text: ID:nBw4gdxGBaFurther company coverage: ATXS.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}